International Stem Cell (ISCO) Prepaid Assets (2010 - 2026)
International Stem Cell (ISCO) posted quarterly Prepaid Assets of $181000.0 for Q4 2025, up 47.15% year-over-year from $123000.0 in Q4 2024, and up 75.73% quarter-over-quarter from $103000.0 in Q3 2025.
International Stem Cell (ISCO) Prepaid Assets (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Prepaid Assets for 16 consecutive years, with $181000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 47.15% year-over-year to $181000.0; the TTM figure through Dec 2025 stood at $181000.0 (up 47.15% YoY), while the FY2025 annual figure was $181000.0, up 47.15% from the prior year.
- Prepaid Assets grew to $181000.0 in Q4 2025 per ISCO's latest filing, from $103000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $437000.0 in Q1 2021 and bottomed at $11000.0 in Q2 2024.
- Historically, Prepaid Assets has averaged $172350.0 across 5 years, with a median of $137000.0 in 2021.
- Annual changes were most pronounced in 2024 — Prepaid Assets slumped 94.84% — and 2025, when it jumped 1781.82%.
- International Stem Cell's Prepaid Assets stood at $135000.0 in 2021, then plunged by 33.33% to $90000.0 in 2022, then advanced by 6.67% to $96000.0 in 2023, then increased by 28.12% to $123000.0 in 2024, then soared by 47.15% to $181000.0 in 2025.
- Business Quant data shows ISCO's Prepaid Assets at $181000.0 in Q4 2025, $103000.0 in Q3 2025, and $207000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 187,000.00 |
| Dec 31, 2025 | 181,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 277,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 119,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 267,000.00 |
| Jun 30, 2023 | 213,000.00 |
| Mar 31, 2023 | 26,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 139,000.00 |
| Jun 30, 2022 | 63,000.00 |
| Mar 31, 2022 | 338,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 174,000.00 |
| Jun 30, 2021 | 416,000.00 |